posted on 2023-08-29, 15:20authored byMarco Magistri, Lanie E. Happ, Jeremy Ramdial, XiaoQing Lu, Vasileios Stathias, Kranthi Kunkalla, Nitin Agarwal, Xiaoyu Jiang, Stephan C. Schürer, Sander R. Dubovy, Jennifer R. Chapman, Francisco Vega, Sandeep Dave, Izidore S. Lossos
Characterization of mutational processes. A, Heat map showing the contribution of each of the 47 COSMIC mutation signatures to each individual tumor. B, Number (top) and proportion (bottom) of mutations in each tumor that are attributed to the top 12 most prevalent signatures. C, Relative enrichment of the top 12 most prevalent signatures in the 20 most recurrently mutated genes.
Funding
HHS | NIH | National Cancer Institute (NCI)
Anthony Rizzo Families Foundation
Jaime Erin Follicular Lymphoma Research Consortium
History
ARTICLE ABSTRACT
We report systematic application of whole-exome sequencing and CN variations in OAMZL, revealing common alterations in regulation of NFAT signaling pathway that may facilitate identification of new therapies.